Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

doi:10.1007/s12185-020-02932-8

Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.

本文言語	英語
ページ（範囲）	431-432
ページ数	2
ジャーナル	International journal of hematology
巻	112
号	3
DOI	https://doi.org/10.1007/s12185-020-02932-8
出版ステータス	出版済み - 9月 1 2020

!!!All Science Journal Classification (ASJC) codes

血液学

文献へのアクセス

10.1007/s12185-020-02932-8

他のファイルとリンク

フィンガープリント

「Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG) (2020). Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z). International journal of hematology, 112(3), 431-432. https://doi.org/10.1007/s12185-020-02932-8

Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z). / for the Fukuoka Blood & Marrow Transplantation Group (FBMTG).
In: International journal of hematology, Vol. 112, No. 3, 01.09.2020, p. 431-432.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG) 2020, 'Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)', International journal of hematology, vol. 112, no. 3, pp. 431-432. https://doi.org/10.1007/s12185-020-02932-8

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG). Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z). International journal of hematology. 2020 9月 1;112(3):431-432. doi: 10.1007/s12185-020-02932-8

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG). / Correction to : Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z). In: International journal of hematology. 2020 ; Vol. 112, No. 3. pp. 431-432.

@article{2db0ede3076a44b5a3b178f00284ec4a,

title = "Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)",

abstract = "In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.",

author = "{for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)} and Hideho Henzan and Ken Takase and Tomohiko Kamimura and Yasuo Mori and Goichi Yoshimoto and Hiromi Iwasaki and Koji Nagafuji and Ryosuke Ogawa and Tetsuya Eto and Naoyuki Uchida and Tomoaki Fujisaki and Koji Kato and Mariko Minami and Yoshikane Kikushige and Koichi Akashi and Toshihiro Miyamoto",

note = "Publisher Copyright: {\textcopyright} 2020, Japanese Society of Hematology.",

year = "2020",

month = sep,

day = "1",

doi = "10.1007/s12185-020-02932-8",

language = "English",

volume = "112",

pages = "431--432",

journal = "International journal of hematology",

issn = "0925-5710",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Correction to

T2 - Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)

AU - for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

AU - Henzan, Hideho

AU - Takase, Ken

AU - Kamimura, Tomohiko

AU - Mori, Yasuo

AU - Yoshimoto, Goichi

AU - Iwasaki, Hiromi

AU - Nagafuji, Koji

AU - Ogawa, Ryosuke

AU - Eto, Tetsuya

AU - Uchida, Naoyuki

AU - Fujisaki, Tomoaki

AU - Kato, Koji

AU - Minami, Mariko

AU - Kikushige, Yoshikane

AU - Akashi, Koichi

AU - Miyamoto, Toshihiro

PY - 2020/9/1

Y1 - 2020/9/1

N2 - In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.

AB - In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.

UR - http://www.scopus.com/inward/record.url?scp=85087717816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087717816&partnerID=8YFLogxK

U2 - 10.1007/s12185-020-02932-8

DO - 10.1007/s12185-020-02932-8

M3 - Comment/debate

C2 - 32643074

AN - SCOPUS:85087717816

SN - 0925-5710

VL - 112

SP - 431

EP - 432

JO - International journal of hematology

JF - International journal of hematology

IS - 3

ER -